Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) EBIT: 2019-2025

Historic EBIT for Legend Biotech (LEGN) over the last 7 years, with Sep 2025 value amounting to -$43.5 million.

  • Legend Biotech's EBIT rose 38.24% to -$43.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$237.2 million, marking a year-over-year increase of 22.47%. This contributed to the annual value of -$2.5 million for FY2024, which is 98.95% up from last year.
  • Latest data reveals that Legend Biotech reported EBIT of -$43.5 million as of Q3 2025, which was up 66.58% from -$130.0 million recorded in Q2 2025.
  • Legend Biotech's 5-year EBIT high stood at $40.5 million for Q4 2024, and its period low was -$204.0 million during Q2 2023.
  • Over the past 3 years, Legend Biotech's median EBIT value was -$70.4 million (recorded in 2024), while the average stood at -$84.8 million.
  • As far as peak fluctuations go, Legend Biotech's EBIT crashed by 34,948.23% in 2022, and later skyrocketed by 127.59% in 2024.
  • Over the past 5 years, Legend Biotech's EBIT (Quarterly) stood at -$88.9 million in 2021, then slumped by 58.07% to -$140.6 million in 2022, then decreased by 4.43% to -$146.8 million in 2023, then spiked by 127.59% to $40.5 million in 2024, then surged by 38.24% to -$43.5 million in 2025.
  • Its last three reported values are -$43.5 million in Q3 2025, -$130.0 million for Q2 2025, and -$104.2 million during Q1 2025.